匯納科技(300609.SZ):控股股東張宏俊因涉嫌對非國家工作人員行賄罪被上海市公安局浦東分局採取刑事拘留強制措施
格隆匯 12 月 22日丨匯納科技(300609.SZ)公佈,公司於2020年12月21日收到公司控股股東、實際控制人兼董事長、總經理張宏俊家屬的通知,張宏俊因涉嫌對非國家工作人員行賄罪被上海市公安局浦東分局採取刑事拘留強制措施。相關事項尚待公安機關進一步調查。
截至目前,公司經營情況正常。公司於2020年12月22日下午召開董事會緊急會議,與會董事一致同意在張宏俊被調查期間,由董事丁遙代為履行公司董事長、總經理及法定代表人職責,詳細情況請參見與本公告同日披露的相關公告。公司管理層將加強經營管理,確保公司經營活動的正常進行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.